JPRN-UMIN000004021招募中未知
Study of oral neurokinin-1 antagonist, aprepitant for the prevention of nausea and vomiting in patients receiving chemotherapy with irinotecan alone or combination of irinotecan plus cisplatin for unresectable gastric cancer - Effect of aprepitant in patients receiving chemotherapy with irinotecan alone or combination of irinotecan plus cisplatin
Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine0 个研究点目标入组 80 人开始时间: 2010年8月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Known hypersensitivity to any component of study regimen 2) Patients receiving pimozide or atazanavir sulfate 3) Patients with active infectious diseases 4) Patients with active interstitial pneumonia or pulmonary fibrosis 5) Patients with large quantity of pleural effusion or ascites 6) Patients with frequent diarrhea (watery) 7) Patients with jaundice 8) Patients with ileus 9) Pregnant or lactating women 10) Patients who are regarded in-eligible by the doctor who participates in this study
研究者
相似试验
招募中
不适用
Effect of oral neurokinin-1 antagonist, aprepitant for chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving carboplatin/paclitaxel chemotherapy.JPRN-UMIN000005317Department of gynecology, Fukuoka University Hospital60
已完成
不适用
Study of efficacy and safety of oral neurokinin-1 antagonist, aprepitant for prevention of chemotherapy-induced nausea and vomiting associated with 5-FU/cisplatin chemotherapy in patients with head and neck cancer.head and neck cancerJPRN-UMIN000005071Department of otolaryngology , Nagasaki University Hospital20
招募中
不适用
Study of NK1-receptor antagonist; aprepitant for prevention of nausea and emesis in patients receiving chemotherapy with irinotecan for gastric cancer.Advanced gastric cancerJPRN-UMIN000011962Gastroenterologic Surgery, Kanazawa University55
招募中
2 期
Efficacy of NK1 receptor antagonist (aprepitant) in the cancer chemotherapies for hematologic malignancies.hematologic malignanciesJPRN-UMIN000006690Kagoshima University Hospital, division of Hematology and Immunology40
已完成
不适用
Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)Venous thrombosisJPRN-UMIN000023747Department of Cardiology and Nephrology, Mie University Graduate School of Medicine1,000